This video is featured in the 2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "NETTER-2 Study - Efficacy and Safety of 177Lu-DOTA-TATE in Newly Diagnosed Advanced Grade 2/3 Gastroenteropancreatic NETs"

88 views
July 8, 2024
Comments 0
Login to view comments. Click here to Login